What's new in oncodermatology in 2015?

被引:0
|
作者
Meyer, N. [1 ,2 ,3 ]
机构
[1] Univ Paul Sabatier Toulouse III, Dermatol, 1 Rue Irene Joliot Curie, F-31059 Toulouse 9, France
[2] Inst Univ Canc Toulouse, F-31059 Toulouse 9, France
[3] INSERM UMR 1037, CRCT, Toulouse, France
来源
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2015年 / 142卷
关键词
Melanoma; Carcinoma; basal cell; Squamous cell; carcinoma; Adnexal carcinoma; Merkel cell; Cutaneous lymphoma; Therapeutics; Biomarker; T-CELL LYMPHOMA; OPEN-LABEL; METASTATIC MELANOMA; PD-L1; EXPRESSION; MEK INHIBITION; COMBINED BRAF; DOUBLE-BLIND; PHASE-II; DABRAFENIB; MULTICENTER;
D O I
10.1016/S0151-9638(16)30005-9
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Oncodermatology is the topic of constant innovation since 5 years. These innovations have drammatically modified the prognostic of skin cancers and induced a change in the paradigm that drives the whole oncology. Once again in 2015, melanoma is the key topic of scientific communication, with promising results. However, unmet clinical needs must be kept in light. Some diseases, such as squamous cell carcinoma or cutaneous lymphoma remain poorly evaluated. This article was designed as a review of litterature. All keywords of oncodermatology were searched in the main journals of dermatology, oncology and internal medicine. Despite methodologic restrictions, the number of articles imposed a choice based on opinion. The final goal was to transmit author's enthousiasm and the most important results. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S36 / S48
页数:13
相关论文
共 50 条
  • [31] Bladder cancer: what's new in 2017
    Karyakin, O. B.
    Kaprin, A. D.
    ONKOUROLOGIYA, 2018, 14 (01): : 157 - 165
  • [32] Linear Endobronchial Ultrasound: What's New?
    He, Tao
    Mehta, Atul C.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 39 (06) : 649 - 660
  • [33] What's New in the Treatment of Actinic Keratoses?
    Frankel, Amylynne
    Goldenberg, Gary
    CUTIS, 2011, 87 (02): : 62 - 64
  • [34] What's Current and What's New in Mesothelioma?
    Leal, J. L.
    Hoang, W.
    Xue, J.
    Dunne, B.
    John, T.
    Harden, S.
    CLINICAL ONCOLOGY, 2022, 34 (11) : 771 - 780
  • [35] What's new in treatment of pancreatic cancer: a patent review (2010-2017)
    Ramos, Maria C.
    Boulaiz, Houria
    Grinan-Lison, Carmen
    Antonio Marchal, Juan
    Vicente, Francisca
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2017, 27 (11) : 1251 - 1266
  • [36] PARP Inhibitors and Radiometabolic Approaches in Metastatic Castration-Resistant Prostate Cancer: What's Now, What's New, and What's Coming?
    Marchetti, Andrea
    Rosellini, Matteo
    Nuvola, Giacomo
    Tassinari, Elisa
    Mollica, Veronica
    Rizzo, Alessandro
    Santoni, Matteo
    Cimadamore, Alessia
    Farolfi, Andrea
    Montironi, Rodolfo
    Fanti, Stefano
    Massari, Francesco
    CANCERS, 2022, 14 (04)
  • [37] Fentanyl for breakthrough cancer pain - what's new?
    Hagelberg, Nora M.
    Olkkola, Klaus T.
    PAIN, 2010, 151 (03) : 565 - 566
  • [38] Atopic dermatitis treatment: what's new on the horizon?
    Panarese, Fabrizio
    Auriemma, Matteo
    Carbone, Angelo
    Amerio, Paolo
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2018, 153 (01): : 95 - 101
  • [39] Advanced Squamous Cell Carcinoma: What's New?
    Tongdee, Emily
    Psomadakis, Corinna
    Marghoob, Nadeem
    Paka, Pavan
    Markowitz, Orit
    CURRENT DERMATOLOGY REPORTS, 2019, 8 (03) : 117 - 121
  • [40] Childhood Pneumonia: What's Unchanged, and What's New?
    Yadav, Krishna Kumar
    Awasthi, Shally
    INDIAN JOURNAL OF PEDIATRICS, 2023, 90 (07) : 693 - 699